Correlation Between Dow Jones and Reata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dow Jones and Reata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dow Jones and Reata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dow Jones Industrial and Reata Pharmaceuticals, you can compare the effects of market volatilities on Dow Jones and Reata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dow Jones with a short position of Reata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dow Jones and Reata Pharmaceuticals.
Diversification Opportunities for Dow Jones and Reata Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Dow and Reata is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Dow Jones Industrial and Reata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reata Pharmaceuticals and Dow Jones is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dow Jones Industrial are associated (or correlated) with Reata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reata Pharmaceuticals has no effect on the direction of Dow Jones i.e., Dow Jones and Reata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dow Jones and Reata Pharmaceuticals
Assuming the 90 days trading horizon Dow Jones is expected to generate 23.53 times less return on investment than Reata Pharmaceuticals. But when comparing it to its historical volatility, Dow Jones Industrial is 22.73 times less risky than Reata Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Reata Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 3,962 in Reata Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 7,005 from holding Reata Pharmaceuticals or generate 176.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 32.06% |
| Values | Daily Returns |
Dow Jones Industrial vs. Reata Pharmaceuticals
Performance |
| Timeline |
Dow Jones and Reata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Dow Jones Industrial
Pair trading matchups for Dow Jones
Reata Pharmaceuticals
Pair trading matchups for Reata Pharmaceuticals
Pair Trading with Dow Jones and Reata Pharmaceuticals
The main advantage of trading using opposite Dow Jones and Reata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dow Jones position performs unexpectedly, Reata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reata Pharmaceuticals will offset losses from the drop in Reata Pharmaceuticals' long position.| Dow Jones vs. Sphere Entertainment Co | Dow Jones vs. Perseus Mining Limited | Dow Jones vs. Titan Machinery | Dow Jones vs. Simon Property Group |
| Reata Pharmaceuticals vs. Sarepta Therapeutics | Reata Pharmaceuticals vs. Krystal Biotech | Reata Pharmaceuticals vs. PTC Therapeutics | Reata Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |